Search

Nancy J. Leith

Examiner (ID: 12198, Phone: (313)446-4874 , Office: P/1636 )

Most Active Art Unit
1636
Art Unit(s)
1636, 1811, 1815, 1941, 1805
Total Applications
1445
Issued Applications
999
Pending Applications
194
Abandoned Applications
284

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 16399157 [patent_doc_number] => 20200340015 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-10-29 [patent_title] => DELIVERY, USE AND THERAPEUTIC APPLICATIONS OF THE CRISPR-CAS SYSTEMS AND COMPOSITIONS FOR TARGETING DISORDERS AND DISEASES USING PARTICLE DELIVERY COMPONENTS [patent_app_type] => utility [patent_app_number] => 16/920982 [patent_app_country] => US [patent_app_date] => 2020-07-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 116384 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -16 [patent_words_short_claim] => 88 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16920982 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/920982
DELIVERY, USE AND THERAPEUTIC APPLICATIONS OF THE CRISPR-CAS SYSTEMS AND COMPOSITIONS FOR TARGETING DISORDERS AND DISEASES USING PARTICLE DELIVERY COMPONENTS Jul 5, 2020 Pending
Array ( [id] => 16541295 [patent_doc_number] => 20200407708 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-12-31 [patent_title] => METHODS AND COMPOSITIONS FOR ASSESSING PROTEIN FUNCTION [patent_app_type] => utility [patent_app_number] => 16/910507 [patent_app_country] => US [patent_app_date] => 2020-06-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11556 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -26 [patent_words_short_claim] => 12 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16910507 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/910507
Methods and compositions for assessing protein function Jun 23, 2020 Issued
Array ( [id] => 16361422 [patent_doc_number] => 20200318173 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-10-08 [patent_title] => NOVEL CRISPR ENZYMES AND SYSTEMS [patent_app_type] => utility [patent_app_number] => 16/909101 [patent_app_country] => US [patent_app_date] => 2020-06-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 206969 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -44 [patent_words_short_claim] => 93 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16909101 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/909101
CRISPR enzymes and systems Jun 22, 2020 Issued
Array ( [id] => 20129433 [patent_doc_number] => 12371737 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2025-07-29 [patent_title] => CRISPR enzymes and systems [patent_app_type] => utility [patent_app_number] => 16/909064 [patent_app_country] => US [patent_app_date] => 2020-06-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 345 [patent_figures_cnt] => 388 [patent_no_of_words] => 201077 [patent_no_of_claims] => 40 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 69 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16909064 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/909064
CRISPR enzymes and systems Jun 22, 2020 Issued
Array ( [id] => 16361372 [patent_doc_number] => 20200318123 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-10-08 [patent_title] => CRISPR-CAS COMPONENT SYSTEMS, METHODS AND COMPOSITIONS FOR SEQUENCE MANIPULATION [patent_app_type] => utility [patent_app_number] => 16/906580 [patent_app_country] => US [patent_app_date] => 2020-06-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 51028 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -27 [patent_words_short_claim] => 141 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16906580 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/906580
CRISPR-CAS COMPONENT SYSTEMS, METHODS AND COMPOSITIONS FOR SEQUENCE MANIPULATION Jun 18, 2020 Pending
Array ( [id] => 16525506 [patent_doc_number] => 20200399586 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-12-24 [patent_title] => GENOME-WIDE RATIONALLY-DESIGNED MUTATIONS LEADING TO ENHANCED LYSINE PRODUCTION IN E. COLI [patent_app_type] => utility [patent_app_number] => 16/904827 [patent_app_country] => US [patent_app_date] => 2020-06-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7358 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 125 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16904827 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/904827
Genome-wide rationally-designed mutations leading to enhanced lysine production in Jun 17, 2020 Issued
Array ( [id] => 16650220 [patent_doc_number] => 10927385 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2021-02-23 [patent_title] => Increased nucleic-acid guided cell editing in yeast [patent_app_type] => utility [patent_app_number] => 16/904405 [patent_app_country] => US [patent_app_date] => 2020-06-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 30 [patent_figures_cnt] => 42 [patent_no_of_words] => 27325 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 114 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16904405 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/904405
Increased nucleic-acid guided cell editing in yeast Jun 16, 2020 Issued
Array ( [id] => 16523732 [patent_doc_number] => 20200397812 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-12-24 [patent_title] => INHIBITORS OF HUMAN EZH2, AND METHODS OF USE THEREOF [patent_app_type] => utility [patent_app_number] => 16/893851 [patent_app_country] => US [patent_app_date] => 2020-06-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 24151 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 53 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16893851 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/893851
INHIBITORS OF HUMAN EZH2, AND METHODS OF USE THEREOF Jun 4, 2020 Abandoned
Array ( [id] => 17890950 [patent_doc_number] => 11453907 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2022-09-27 [patent_title] => Crispr effector system based coronavirus diagnostics [patent_app_type] => utility [patent_app_number] => 16/894670 [patent_app_country] => US [patent_app_date] => 2020-06-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 46 [patent_figures_cnt] => 55 [patent_no_of_words] => 67959 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 133 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16894670 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/894670
Crispr effector system based coronavirus diagnostics Jun 4, 2020 Issued
Array ( [id] => 16445105 [patent_doc_number] => 10837021 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2020-11-17 [patent_title] => Curing for recursive nucleic acid-guided cell editing [patent_app_type] => utility [patent_app_number] => 16/892679 [patent_app_country] => US [patent_app_date] => 2020-06-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 40 [patent_figures_cnt] => 51 [patent_no_of_words] => 36360 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 335 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16892679 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/892679
Curing for recursive nucleic acid-guided cell editing Jun 3, 2020 Issued
Array ( [id] => 17867060 [patent_doc_number] => 20220289795 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-09-15 [patent_title] => EFFICIENT METHOD FOR PREPARING PPR PROTEIN AND USE OF THE SAME [patent_app_type] => utility [patent_app_number] => 17/614231 [patent_app_country] => US [patent_app_date] => 2020-05-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 27629 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -16 [patent_words_short_claim] => 989 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17614231 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/614231
EFFICIENT METHOD FOR PREPARING PPR PROTEIN AND USE OF THE SAME May 28, 2020 Pending
Array ( [id] => 19504983 [patent_doc_number] => 12116394 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2024-10-15 [patent_title] => Loss of function mutations in [patent_app_type] => utility [patent_app_number] => 16/884875 [patent_app_country] => US [patent_app_date] => 2020-05-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 9 [patent_no_of_words] => 35692 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 83 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16884875 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/884875
Loss of function mutations in May 26, 2020 Issued
Array ( [id] => 16296304 [patent_doc_number] => 20200282027 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-09-10 [patent_title] => SEQUENCE SPECIFIC ANTIMICROBIALS [patent_app_type] => utility [patent_app_number] => 16/877030 [patent_app_country] => US [patent_app_date] => 2020-05-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10471 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -22 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16877030 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/877030
Sequence specific antimicrobials May 17, 2020 Issued
Array ( [id] => 16296304 [patent_doc_number] => 20200282027 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-09-10 [patent_title] => SEQUENCE SPECIFIC ANTIMICROBIALS [patent_app_type] => utility [patent_app_number] => 16/877030 [patent_app_country] => US [patent_app_date] => 2020-05-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10471 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -22 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16877030 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/877030
Sequence specific antimicrobials May 17, 2020 Issued
Array ( [id] => 19909279 [patent_doc_number] => 12285466 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2025-04-29 [patent_title] => Sequence specific antimicrobials [patent_app_type] => utility [patent_app_number] => 16/877010 [patent_app_country] => US [patent_app_date] => 2020-05-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 8 [patent_no_of_words] => 5942 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 167 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16877010 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/877010
Sequence specific antimicrobials May 17, 2020 Issued
Array ( [id] => 17466752 [patent_doc_number] => 11273209 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2022-03-15 [patent_title] => Methods and compositions for RNA-guided treatment of HIV infection [patent_app_type] => utility [patent_app_number] => 16/875271 [patent_app_country] => US [patent_app_date] => 2020-05-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 25 [patent_figures_cnt] => 48 [patent_no_of_words] => 22270 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 134 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16875271 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/875271
Methods and compositions for RNA-guided treatment of HIV infection May 14, 2020 Issued
Array ( [id] => 16686828 [patent_doc_number] => 20210069303 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-03-11 [patent_title] => METHODS AND COMPOSITIONS FOR RNA-GUIDED TREATMENT OF HIV INFECTION [patent_app_type] => utility [patent_app_number] => 16/874295 [patent_app_country] => US [patent_app_date] => 2020-05-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 22227 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -8 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16874295 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/874295
Methods and compositions for RNA-guided treatment of HIV infection May 13, 2020 Issued
Array ( [id] => 19474089 [patent_doc_number] => 12104167 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2024-10-01 [patent_title] => Storage through iterative DNA editing [patent_app_type] => utility [patent_app_number] => 15/931570 [patent_app_country] => US [patent_app_date] => 2020-05-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 19405 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 193 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15931570 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/931570
Storage through iterative DNA editing May 12, 2020 Issued
Array ( [id] => 16506446 [patent_doc_number] => 20200385702 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-12-10 [patent_title] => RECOMBINANT TYPE I CRISPR-CAS SYSTEM [patent_app_type] => utility [patent_app_number] => 15/930678 [patent_app_country] => US [patent_app_date] => 2020-05-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 29792 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15930678 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/930678
Recombinant type I CRISPR-CAS system May 12, 2020 Issued
Array ( [id] => 16326823 [patent_doc_number] => 20200297788 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-09-24 [patent_title] => COMBINATION METHOD FOR TREATMENT OF CANCER [patent_app_type] => utility [patent_app_number] => 16/861660 [patent_app_country] => US [patent_app_date] => 2020-04-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 17704 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -16 [patent_words_short_claim] => 50 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16861660 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/861660
COMBINATION METHOD FOR TREATMENT OF CANCER Apr 28, 2020 Abandoned
Menu